Skip to main content
. 2021 Dec 10;11(62):39328–39342. doi: 10.1039/d1ra07504g

A few of the potent 4-thiazolidinone derivatives with the respective diseases and target enzyme.

Sl Compound Targeting enzyme Disease/therapeutic use
1 graphic file with name d1ra07504g-u7.jpg Inhibition of oxidation of tricarboxylic acid cycle substrates such as, α-ketogluterate, citrate, pyruvate and β-hydroxybutyrate30 Epilepsy
2 graphic file with name d1ra07504g-u8.jpg Tyrosine phosphatase B45 Tuberculosis
3 graphic file with name d1ra07504g-u9.jpg Metalloproteinase (MMP-13)46 Osteoarthritis
4 graphic file with name d1ra07504g-u10.jpg E. coli glycosyltransferase MurG and the C. albicans protein mannosyltransferase1 (PMT1)47 Human African trypanosomiasis (HAT)
5 graphic file with name d1ra07504g-u11.jpg HIV Reverse transcriptase (RT)27